Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Net Income towards Common Stockholders: 2019-2025

Historic Net Income towards Common Stockholders for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $50.9 million.

  • Harmony Biosciences Holdings' Net Income towards Common Stockholders rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 44.38%. This contributed to the annual value of $117.5 million for FY2024, which is 8.82% down from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Net Income towards Common Stockholders is $50.9 million, which was up 27.88% from $39.8 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Net Income towards Common Stockholders registered a high of $87.9 million during Q3 2022, and its lowest value of -$9.6 million during Q3 2021.
  • Over the past 3 years, Harmony Biosciences Holdings' median Net Income towards Common Stockholders value was $38.3 million (recorded in 2024), while the average stood at $33.6 million.
  • Examining YoY changes over the last 5 years, Harmony Biosciences Holdings' Net Income towards Common Stockholders showed a top increase of 11,020.19% in 2021 and a maximum decrease of 134.41% in 2021.
  • Harmony Biosciences Holdings' Net Income towards Common Stockholders (Quarterly) stood at $22.7 million in 2021, then spiked by 113.56% to $48.5 million in 2022, then plummeted by 72.81% to $13.2 million in 2023, then spiked by 62.84% to $21.5 million in 2024, then increased by 10.35% to $50.9 million in 2025.
  • Its last three reported values are $50.9 million in Q3 2025, $39.8 million for Q2 2025, and $45.6 million during Q1 2025.